Post Profile






Samsung's bio-drug unit to raise $2 bn in upcoming IPO

Samsung's drug-manufacturing unit plans to raise as much as $2.0 billion in November with what looks set to be South Korea's third-largest initial public offering (IPO).
read more

share
See more about: South Korea

Related Posts


Samsung Galaxy S sales surpass 300,000 units in 19 days in South Korea

Technology / Gadgets : BGR (Boy Genius Report)

Why do we love South Korea? Because its got Seoul, of course. The YONHAP News Agency is reporting that the Samsung Galaxy S has sold over 300,000 units, in just 19 days, on South Korea’s largest wireless carrier; SK Telecom. Samsung...

Samsung offering personal engraving for Galaxy Note in South Korea

Technology / Mobile : Android Central

Samsung's Galaxy Note publicity machine continues to churn, with the manufacturer now hoping to win over consumers in its native South Korea a unique personalization option. According to Samsung's official Flickr stream, personalize...

Korea’s SK Telecom and Samsung reportedly joined Yahoo in Hulu takeover talks

Technology : The Next Web Blog

South Korea’s largest mobile operator SK Telecom are reported to have approached Samsung Electronics and Yahoo to discuss a possible takeover of online video service Hulu before scrapping the plan, Yonhap News reports. It is believe...

Samsung to Invest $740 Million in New Drug Facility

Technology : Tech - WSJ.com

Samsung BioLogics said it would construct a new facility in South Korea that will double its production capacity and make it the world’s largest contract drug maker.

Samsung will reportedly make 5M Galaxy S7 phones ahead of February launch

Technology : Venture Beat

Samsung, the world's top smartphone maker, plans an initial production run of about 5 million of its upcoming Galaxy S7 smartphones, South Korea's Electronic Times reported on Monday, citing unnamed sources.

Comments


Copyright © 2016 Regator, LLC